£40 million, 300,000 patients and some difficult questions

The government has announced a £40 million programme to help general practice support vulnerable patients this winter. The aim is to keep people well at home and prevent avoidable hospital admissions. Up to 300,000 patients could benefit.

The ring-fenced funding is aimed at people most at risk of becoming seriously unwell, particularly those with heart disease, frailty, emphysema and other forms of chronic obstructive pulmonary disease (COPD). Practices will identify the patients they consider most at risk, and primary care networks (PCNs) can receive £126 for each eligible patient supported. Support could include medication reviews, health checks, home assessments and nurse-led respiratory clinics.

The focus on proactive care has been widely welcomed. The Royal College of GPs (RCGP), the National Association of Primary Care (NAPC) and Asthma + Lung UK all backed the principle of reaching high-risk patients before they reach crisis point.

How the scheme is funded is a different matter, and it has caused real concern across general practice. That concern deserves to be taken seriously.

Why the funding route matters

The Department of Health and Social Care has confirmed that the £40 million is reallocated from existing general practice budgets for 2026/27, rather than new investment.

GPs and their representative bodies have raised concerns that the money is being moved from individual practices to PCNs at a time when core practice funding is already under strain. Some have warned this could affect practice sustainability and staffing over winter, with practices in more deprived areas likely to feel it most.

The RCGP has also stressed that the scheme must recognise health inequalities and give practices flexibility, and that short-term initiatives alone cannot deliver lasting improvements for patients with complex needs.

These concerns deserve to be heard. GP practices are the foundation of primary care, and a scheme that asks more of them while core income falls will feel like a step backwards to many teams. Our clinical pharmacists work inside GP practices every day, and we see that pressure first-hand.

But the patients this funding is aimed at are real, and winter will arrive regardless. So the question we want to put to colleagues is a practical one. However the scheme was funded, how do we make sure it reaches the patients who need it, without adding to the load on already stretched practice teams?

Where proactive winter care starts

Many of the patients this scheme targets are already well known to their practice teams. People living with frailty, heart disease or COPD often take several medicines, and winter is when small gaps matter most. A poor inhaler technique, an out-of-date rescue pack or a medicine that raises falls risk can be the difference between staying well at home and a hospital admission.

A structured medication review is one of the most practical things that can happen before the cold weather sets in. For COPD, that means checking inhaler technique and adherence, and making sure patients know when and how to use a rescue pack. For frailty, it means looking at medicines that increase falls risk and simplifying regimens where possible. For heart disease, it means checking treatment is optimised and monitoring is up to date.

Every week, our team at Clinical Pharmacist Solutions (CPS) carries out these reviews in GP practices and PCNs, working as part of the practice team. Done well, this kind of work can ease the clinical load on GPs and practice nurses rather than add to it. It is not a replacement for the knowledge and continuity that practices hold. It is one way of supporting it.

Making it work for practices as well as patients

For this scheme to help, it has to work for the practices delivering it. That raises questions we would like to explore with colleagues across primary care.

  • How will PCNs and member practices agree which patients are identified, and how funding reaches the teams doing the work?
  • Can practices that have lost income through list validation take part on fair terms?
  • Is the timeframe realistic, now that winter pressures have already begun?
  • How do we make sure support reaches patients in more deprived areas, where need is often highest?
  • What happens to these patients once winter is over and the funding ends?

One winter is not enough

The RCGP, NAPC and NHS Alliance have all called for proactive care to become a lasting part of how neighbourhood health is funded and delivered. We agree. Patients living with frailty and long-term conditions need consistent support all year round, not only when hospitals are under the most pressure.

As integrated care boards (ICBs) plan for winter and beyond, we think a few questions deserve wider discussion.

  • How can ICBs help practices and PCNs plan proactive care beyond a single season?
  • How will the scheme’s evaluation capture its impact on practice workload, not just hospital admissions?
  • What would sustainable, recurrent funding for proactive care in general practice look like?

We want to hear from you

We would like to hear from GP partners, practice managers, PCN clinical directors, clinical pharmacists, practice nurses, ICB teams and anyone else preparing primary care for winter.

  • How is your practice or PCN approaching the scheme?
  • What concerns do you have about how it will work locally?
  • What would make proactive winter care sustainable beyond this year?

Share your thoughts in the comments on our LinkedIn post, or get in touch to talk about how our clinical pharmacists support practices and PCNs with medication reviews for patients most at risk this winter.